Quantcast

Latest Alcohols Stories

2014-06-10 23:16:02

Avail is conducting a phase 1, open-label pharmacokinetic and pharmacodynamic study of a single dose of an experimental drug in subjects with hepatic impairment and in matched healthy volunteers. DeLand, FL (PRWEB) June 10, 2014 To see if you qualify for this Hepatic Impairment Clinical Trial in DeLand, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost to participate, no insurance is required, and you may...

2014-06-10 08:29:27

RALEIGH, N.C., June 10, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at two important upcoming healthcare conferences: 34(th) Annual William Blair Growth Stock ConferenceWednesday, June 11, 20143:20 PM Central Time (4:20 PM Eastern Time)Four Seasons Hotel, Chicago, IL Wells Fargo 2014 Healthcare ConferenceTuesday, June 17, 20144:40 PM Eastern...

2014-06-06 23:01:39

TreatmentHelp helps debunk the claim that medication prescribed by a physician is always safer than illicit drugs. Delray Beach, FL (PRWEB) June 06, 2014 Prescription drugs have started to gain the notoriety of illicit drugs, especially among teenagers and individuals to whom the drugs were not prescribed. Taking prescription drugs without the supervision of a physician can be extremely dangerous and life-threatening to overall health and well-being. Some of the most commonly abused...

2014-06-06 23:01:17

A nasal-spray version of Naloxone, a heroin/opiate overdose-reversal drug, is in the works in Kentucky. (PRWEB) June 06, 2014 As reported by USA Today in the article Nasal Spray For Heroin Antidote Under Development(5/31), a Kentucky doctor has been successful in advocating a nasal spray medicine to reverse a heroin or opiate overdose. Dr. Daniel Wermeling has made a deal with a pharmaceutical company to create a nasal spray version of naloxone, a common medicine used on persons who are...

2014-06-06 16:24:14

First and Only FDA-Approved Buccal Film Formulation of Buprenorphine and Naloxone to Compete in the $1.7 Billion and Growing U.S. Opioid Dependence Market RALEIGH, N.C., June 6, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) received approval of the New Drug Application (NDA) for BUNAVAIL(TM) (buprenorphine and naloxone) buccal film (CIII) from the U.S. Food and Drug Administration (FDA). BUNAVAIL is indicated for the maintenance treatment of...

2014-06-05 23:11:58

Natural supplement company, PuraVida Labs, releases breakthrough new Forskolin formulation that is backed by science and helps women lose weight. Victor, NY (PRWEB) June 05, 2014 Forskolin is a natural extract that has been credited as an effective fat loss aid that soared to popularity when it was endorsed by a well-known television doctor recently. This week, PuraVida Labs, a natural supplement company, has released its Forskolin Extreme Thermogenesis Formula on Amazon. Company...

2014-06-05 13:33:09

University of Michigan Health System With naloxegol, adults found relief from opioid-induced constipation Pain medicines often lead to constipation for patients seeking long-term pain relief, but an investigational once-daily drug may help, according to study led by the University of Michigan Health System. Globally, approximately 28 million to 35 million, or nearly half, of patients taking opioids for long-term pain develop constipation. Laxatives provide sub-optimal relief. The...

2014-06-05 12:29:48

CHICAGO, June 5, 2014 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) issued on March 14, 2014 revised guidance, "Requirements for Hospital Medication Administration, Particularly Intravenous (IV) Medications and Post-Operative Care of Patients Receiving IV Opioids". http://photos.prnewswire.com/prnvar/20131024/CG03341LOGO In an open letter to CMS discussing the guidance, the Physician-Patient Alliance for Health & Safety applauds CMS for this guidance as...

2014-06-05 12:24:18

HOUSTON, June 5, 2014 /PRNewswire/ -- G2X Energy, Inc. ("G2X") announced today that the State of Louisiana and the Federal EPA have granted its wholly-owned subsidiary, Big Lake Fuels LLC, the required air permits to construct and operate a natural gas-to-gasoline facility in Lake Charles, Louisiana. The permits, issued by the Louisiana Department of Environmental Quality ("LDEQ") on May 23rd, are the first permits to allow for the construction and operation of a commercial scale...

2014-06-05 08:27:57

JAMA Psychiatry Study confirms Waismann Method research that heroin addiction is prevalent in the inner-city as well as in white suburbs and rural areas. BEVERLY HILLS, Calif., June 5, 2014 /PRNewswire/ -- A research paper published in the May 28, 2014 issue of JAMA Psychiatry a paper entitled "The Changing Face of Heroin Use in the United States A Retrospective Analysis of the Past 50 Years" concluded that heroin abuse has left low-income urban areas and has become prevalent in...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related